leisure time -WSS

leisure time

author：focus 2025-10-01 15:39:38 - browse：4

Elizabeth Warren speaks behind a podium with a sign that reads "ABORTION RIGHTS FOR ALL" — Sen. Elizabeth Warren (D-Mass.) J. Scott Applewhite/AP

WASHINGTON — Sen. Elizabeth Warren (D-Mass.) is launching a fresh round of questioning on states’ limits to abortion rights as a battle on medication abortion hangs in the balance at a federal court.

Warren and three other Democratic senators sent letters late last week to five major health care worker and pharmacy groups interrogating how last year’s U.S. Supreme Court decision reversing national abortion rights has affected health care access and providers’ treatment of patients.

It’s not the first time the Massachusetts Democrat has aimed questions at these organizations, which include the American Medical Association, Physicians for Reproductive Health, National Nurses United, the American Pharmacists Association, and the American Hospital Association. She asked the same set of groups last summer how the U.S. Supreme Court’s overturn of Roe v. Wade impacted women’s health care, and reported in October that the groups warned about “diminished access” to pregnancy care and abortion bans that “will exacerbate existing health inequities.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： What affirmative action's end means to a medical student

explore

hotspot

WSS

Videos point to link between seizures and unexplained toddler deaths

Prescription digital therapeutics are key to pharma’s future

Antibiotic resistance and the global rise in human conflict

Federal weight loss drug coverage is 30 years out of date

Penis shrinkage, a side effect of prostate cancer surgery, is temporary

AdventHealth escalates lawsuit against insurance vendor Multiplan

knowledge

leisure time

focus

The high cost of giving birth even with insurance

Prescription digital therapeutics are key to pharma’s future

Medical leaders decry Supreme Court decision on affirmative action

The wait for US passports is creating travel purgatory and snarling summer plans

In age of alternative facts, a scholarly course on calling out crap

Why psychiatrists like me stop taking insurance

Jerome Adams on the need for new antivirals for Covid

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

Novavax promises a turnaround & Lilly roils the obesity market

The biotech scorecard for Q3: 15 stock

entertainment

UpToDate has a racism problem: Dr. Stanley Goldfarb

Trump’s hydroxychloroquine hype: a risk to my treatment and to him

Prescription digital therapeutics are key to pharma’s future

The biotech scorecard for Q3: 15 stock

A letter from the executive editor: The 2023 STATUS List

At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

explore

hotspot

knowledge

leisure time